Optimal Treatment of Patients With Left Ventricular Dysfunction and Severe Coronary Artery Disease

Circulation. 2018 Nov 6;138(19):2079-2080. doi: 10.1161/CIRCULATIONAHA.117.030840.

Authors

Michael J Domanski¹, Michael E Farkouh²

Affiliations

¹ University of Maryland School of Medicine, Baltimore (M.J.D.).
² Peter Munk Cardiac Center, Toronto General Hospital, Ontario, Canada. Heart and Stroke Richard Lewar Centre of Excellence, University of Toronto, Ontario, Canada (M.E.F.).

PMID: 30474419
DOI: 10.1161/CIRCULATIONAHA.117.030840

No abstract available

Keywords: coronary artery disease; ischemic cardiomyopathy; revascularization.

MeSH terms

Cardiovascular Agents / adverse effects
Cardiovascular Agents / therapeutic use*
Clinical Decision-Making
Coronary Artery Bypass* / adverse effects
Coronary Artery Disease / complications
Coronary Artery Disease / diagnosis
Coronary Artery Disease / physiopathology
Coronary Artery Disease / therapy*
Humans
Patient Selection
Percutaneous Coronary Intervention* / adverse effects
Risk Factors
Severity of Illness Index
Treatment Outcome
Ventricular Dysfunction, Left / diagnosis
Ventricular Dysfunction, Left / etiology*
Ventricular Dysfunction, Left / physiopathology
Ventricular Function, Left*

Substances

Cardiovascular Agents